| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage; booster dose
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|